DECACYCLO-[12.7.0.0(1,20).0(2,6).0(4,11).0(5,9).0(7,20).0(10,17).0(12,16).0(15,19)]-HENICOSANE
Compound with spectra: 1 NMR
![DECACYCLO-[12.7.0.0(1,20).0(2,6).0(4,11).0(5,9).0(7,20).0(10,17).0(12,16).0(15,19)]-HENICOSANE](/api/compound/DhorxCDqEXu.png?ph=true&h=300&w=458 "DECACYCLO-[12.7.0.0(1,20).0(2,6).0(4,11).0(5,9).0(7,20).0(10,17).0(12,16).0(15,19)]-HENICOSANE")
| SpectraBase Compound ID | DhorxCDqEXu |
|---|---|
| InChI | InChI=1S/C21H24/c1-6-14-7-2-12-19-13-4-9(17(7)19)15(14)8-3-11-18(16(6)8)10(1)20(12)5-21(11,13)20/h6-19H,1-5H2/t6-,7+,8+,9-,10-,11+,12+,13-,14?,15?,16-,17+,18+,19-,20+,21- |
| InChIKey | CIYOKSBLYZALCK-ASKUOAMDSA-N |
| Mol Weight | 276.42 g/mol |
| Molecular Formula | C21H24 |
| Exact Mass | 276.187801 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
UNDECACYCLO-[13.7.0(1,21).0(2,6).0(4,12).0(5,9).0(7,21).0(10,12).0(10,18).0(13,17).0(16,20)]-DOCOSANE
21-OXADECACYCLO-[12.7.0.0(1,20).0(2,6).0(4,11).0(5,9).0(7,20).0(10,17).0(12,16).0(15,19)]-HENICOSANE
10,11-Dicarbomethoxymethyl-hexacyclo(7.3.0.0/2,8/.0/3,7/.0/4,11/.0/6,10/)tridecane
Octadecahydro-7F-hydroxymethyl-1,6,7-metheno-1H-cyclopenta(3,4)pentaleno(2,1,6-gha)pentaleno(1,2,3-cd)pentalen-2-ol
1,11-DIMETHYLNONACYCLO-[12.6.0.0(2,6).0(4,11).0(5,9).0(7,20).0(10,17).0(12,16).0(15,19)]-ICOSANE
UNDECACYCLO-[11.11.0.0(1,6).0(2,14).0(2,21).0(3,8).0(7,12).0(9,14).0(13,18).0(15,20).0(19,24)]-TETRACOSANE
2-Bromoheptacyclo[8.4.0.0(2,12).0(3,8).0(4,6).0(5,9).0(11,13)]tetradecane
6H-indolo[2,3-b]quinoxaline, 9-bromo-6-propyl-
1,10-DIMETHYLNONACYCLO-[12.6.0.0(2,6).0(4,11).0(5,9).0(7,20).0(10,17).0(12,16).0(15,19)]-ICOSANE
6H-indolo[2,3-b]quinoxaline, 6-[[4-(pentyloxy)phenyl]methyl]-
| Title | Journal or Book | Year |
|---|---|---|
| The Pagodane Route to Dodecahedranes Unsaturated (Hyperstable) and Saturated Bissecododecahedranes | Chemische Berichte | 1992 |